Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Travis S Hughes

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Molecular Pharmacology|October 23, 2024
Agonists of the Nuclear Receptor PPARγ Can Produce Biased SignalingMariah L Rayl, Michelle D Nemetchek, Andrew H Voss, et al.
Plos One|August 5, 2015
Deconvolution of Complex 1D NMR Spectra Using Objective Model SelectionTravis S Hughes, Henry D Wilson, Ian Mitchelle S de Vera, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2022
A structural mechanism of nuclear receptor biased agonismMichelle D Nemetchek, Ian M Chrisman, Mariah L Rayl, et al.
The Journal of Biological Chemistry|May 30, 2014
Structure of REV-ERBβ ligand-binding domain bound to a porphyrin antagonistEdna Matta-Camacho, Subhashis Banerjee, Travis S Hughes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2008
Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteinsTravis S Hughes, Stephen J Langer, Kirk W Johnson, et al.
The Journal of Gene Medicine|June 18, 2009
Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expressionTravis S Hughes, Stephen J Langer, Salla I Virtanen, et al.
Nature Chemical Biology|March 26, 2013
Ligand-binding dynamics rewire cellular signaling via estrogen receptor-αSathish Srinivasan, Jerome C Nwachukwu, Alex A Parent, et al.
Journal of Medicinal Chemistry|October 27, 2016
Probing the Complex Binding Modes of the PPARγ Partial Agonist 2-Chloro-N-(3-chloro-4-((5-chlorobenzo[d]thiazol-2-yl)thio)phenyl)-4-(trifluoromethyl)benzenesulfonamide (T2384) to Orthosteric and Allosteric Sites with NMR SpectroscopyTravis S Hughes, Jinsai Shang, Richard Brust, et al.
Elife|December 22, 2018
Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγJinsai Shang, Richard Brust, Sarah A Mosure, et al.
Nature Communications|December 22, 2019
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγZahra Heidari, Ian M Chrisman, Michelle D Nemetchek, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Molecular Pharmacology|October 23, 2024
Agonists of the Nuclear Receptor PPARγ Can Produce Biased SignalingMariah L Rayl, Michelle D Nemetchek, Andrew H Voss, et al.
Plos One|August 5, 2015
Deconvolution of Complex 1D NMR Spectra Using Objective Model SelectionTravis S Hughes, Henry D Wilson, Ian Mitchelle S de Vera, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2022
A structural mechanism of nuclear receptor biased agonismMichelle D Nemetchek, Ian M Chrisman, Mariah L Rayl, et al.
The Journal of Biological Chemistry|May 30, 2014
Structure of REV-ERBβ ligand-binding domain bound to a porphyrin antagonistEdna Matta-Camacho, Subhashis Banerjee, Travis S Hughes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2008
Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteinsTravis S Hughes, Stephen J Langer, Kirk W Johnson, et al.
The Journal of Gene Medicine|June 18, 2009
Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expressionTravis S Hughes, Stephen J Langer, Salla I Virtanen, et al.
Nature Chemical Biology|March 26, 2013
Ligand-binding dynamics rewire cellular signaling via estrogen receptor-αSathish Srinivasan, Jerome C Nwachukwu, Alex A Parent, et al.
Journal of Medicinal Chemistry|October 27, 2016
Probing the Complex Binding Modes of the PPARγ Partial Agonist 2-Chloro-N-(3-chloro-4-((5-chlorobenzo[d]thiazol-2-yl)thio)phenyl)-4-(trifluoromethyl)benzenesulfonamide (T2384) to Orthosteric and Allosteric Sites with NMR SpectroscopyTravis S Hughes, Jinsai Shang, Richard Brust, et al.
Elife|December 22, 2018
Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγJinsai Shang, Richard Brust, Sarah A Mosure, et al.
Nature Communications|December 22, 2019
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγZahra Heidari, Ian M Chrisman, Michelle D Nemetchek, et al.
Pageof 3